Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 13

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

A shedding soluble form of interleukin-17 receptor D exacerbates collagen-induced arthritis through facilitating TNF-α-dependent receptor clustering

Liu, Sihan, Fu, Yanxia, Mei, Kunrong, Jiang, Yinan, Sun, Xiaojun, Wang, Yinyin, Ren, Fangli, Jiang, Congshan, Meng, Liesu, Lu, Shemin, Qin, Zhihai, Dong, Chen, Wang, Xinquan, Chang, Zhijie, Yang, Shigao · 2021 · Cellular & Molecular Immunology

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41423-020-00548-w

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 39

  1. Choy, E. H. & Panayi, G. S. Cytokine pathways and joint inflammation in rheumatoid arthritis. N. Engl. J. Med. 344, 907–916 (2001). · DOI · Paper page
  2. Feldmann, M. & Maini, R. N. Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases. Nat. Med. 9, 1245–1250 (2003). · DOI · Paper page
  3. McInnes, I. B. & Schett, G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat. Rev. Immunol. 7, 429–442 (2007). · DOI · Paper page
  4. McInnes, I. B., Buckley, C. D. & Isaacs, J. D. Cytokines in rheumatoid arthritis—shaping the immunological landscape. Nat. Rev. Rheumatol. 12, 63–68 (2016). · DOI · Paper page
  5. Probert, L. TNF and its receptors in the CNS: The essential, the desirable and the deleterious effects. Neuroscience 302, 2–22 (2015). · DOI · Paper page
  6. Locksley, R. M., Killeen, N. & Lenardo, M. J. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104, 487–501 (2001). · DOI · Paper page
  7. Chan, F. K. et al. A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. Science 288, 2351–2354 (2000). · DOI · Paper page
  8. Williams, R. O., Feldmann, M. & Maini, R. N. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc. Natl Acad. Sci. USA 89, 9784–9788 (1992). · DOI · Paper page
  9. Deng, G. M., Zheng, L., Chan, F. K. & Lenardo, M. Amelioration of inflammatory arthritis by targeting the pre-ligand assembly domain of tumor necrosis factor receptors. Nat. Med. 11, 1066–1072 (2005). · DOI
  10. Su, Y. et al. Interleukin-17 receptor D constitutes an alternative receptor for interleukin-17A important in psoriasis-like skin inflammation. Sci. Immunol. 4, eaau9657 (2019). · DOI
  11. Rong, Z. et al. IL-17RD (Sef or IL-17RLM) interacts with IL-17 receptor and mediates IL-17 signaling. Cell Res. 19, 208–215 (2009). · DOI
  12. Mellett, M. et al. Orphan receptor IL-17RD tunes IL-17A signalling and is required for neutrophilia. Nat. Commun. 3, 1119 (2012). · DOI
  13. Fuchs, Y. et al. Sef is an inhibitor of proinflammatory cytokine signaling, acting by cytoplasmic sequestration of NF-kappaB. Dev. Cell. 23, 611–623 (2012). · DOI
  14. Mellett, M. et al. Orphan receptor IL-17RD regulates Toll-like receptor signalling via SEFIR/TIR interactions. Nat. Commun. 6, 6669 (2015). · DOI
  15. Yang, S. et al. Tumor necrosis factor receptor 2 (TNFR2).interleukin-17 receptor D (IL-17RD) heteromerization reveals a novel mechanism for NF-kappaB activation. J. Biol. Chem. 290, 861–871 (2015). · DOI
  16. Yang, S. et al. A novel multifunctional compound camellikaempferoside B decreases abeta production, interferes with abeta aggregation, and prohibits abeta-mediated neurotoxicity and neuroinflammation. ACS Chem. Neurosci. 7, 505–518 (2016). · DOI
  17. Jiang, C. et al. MicroRNA-26a negatively regulates toll-like receptor 3 expression of rat macrophages and ameliorates pristane induced arthritis in rats. Arthritis Res. Ther. 16, R9 (2014). · DOI
  18. Vingsbo, C. et al. Pristane-induced arthritis in rats: a new model for rheumatoid arthritis with a chronic disease course influenced by both major histocompatibility complex and non-major histocompatibility complex genes. Am. J. Pathol. 149, 1675–1683 (1996).
  19. Delgado, Mario, Martinez, C., Leceta, J. & Gomariz, R. P. Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease. Nat. Med. 7, 563–568 (2001). · DOI · Paper page
  20. Chyuan, I.-T., Tsai, H.-F., Liao, H.-J., Wu, C.-S. & Hsu, P.-N. An apoptosis-independent role of TRAIL in suppressing joint inflammation and inhibiting T-cell activation in inflammatory arthritis. Cell. Mol. Immunol. 14, 1–12 (2017). · DOI
  21. Zunke, F. & Rose-John, S. The shedding protease ADAM17: Physiology and pathophysiology. Biochim. Biophys. Acta Mol. Cell Res. 1864, 2059–2070 (2017). · DOI · Paper page
  22. Caescu, C. I., Jeschke, G. R. & Turk, B. E. Active-site determinants of substrate recognition by the metalloproteinases TACE and ADAM10. Biochem. J. 424, 79–88 (2009). · DOI · Paper page
  23. Xiong, S. et al. hSef inhibits PC-12 cell differentiation by interfering with Ras-mitogen-activated protein kinase MAPK signaling. J. Biol. Chem. 278, 50273–50282 (2003). · DOI
  24. Trimble, R. B. & Tarentino, A. L. Identification of distinct endoglycosidase (endo) activities in Flavobacterium meningosepticum: endo F1, endo F2, and endo F3. Endo F1 and endo H hydrolyze only high mannose and hybrid glycans. J. Biol. Chem. 266, 1646–1651 (1991). · DOI · Paper page
  25. Pinckard, J. K., Sheehan, K. C. & Schreiber, R. D. Ligand-induced formation of p55 and p75 tumor necrosis factor receptor heterocomplexes on intact cells. J. Biol. Chem. 272, 10784–10789 (1997). · DOI
  26. Sidibe, A. et al. Soluble VE-cadherin in rheumatoid arthritis patients correlates with disease activity: evidence for tumor necrosis factor alpha-induced VE-cadherin cleavage. Arthritis Rheum. 64, 77–87 (2012). · DOI
  27. Zhang, Y. et al. LAIR-1 shedding from human fibroblast-like synoviocytes in rheumatoid arthritis following TNF-alpha stimulation. Clin. Exp. Immunol. 192, 193–205 (2018). · DOI
  28. Nielsen, M. A. et al. A disintegrin and metalloprotease-17 and galectin-9 are important regulators of local 4-1BB activity and disease outcome in rheumatoid arthritis. Rheumatology 55, 1871–1879 (2016). · DOI
  29. Liu, F. L., Wu, C. C. & Chang, D. M. TACE-dependent amphiregulin release is induced by IL-1beta and promotes cell invasion in fibroblast-like synoviocytes in rheumatoid arthritis. Rheumatology 53, 260–269 (2014). · doi:10.1093/rheumatology/ket350
  30. Gjelstrup, L. C. et al. Shedding of large functionally active CD11/CD18 Integrin complexes from leukocyte membranes during synovial inflammation distinguishes three types of arthritis through differential epitope exposure. J. Immunol. 185, 4154–4168 (2010). · DOI
  31. Xie, J. & Wang, H. Semaphorin 7A as a potential immune regulator and promising therapeutic target in rheumatoid arthritis. Arthritis Res. Ther. 19, 10 (2017). · doi:10.1186/s13075-016-1217-5
  32. Di Giovine, F. S., Nuki, G. & Duff, G. W. Tumour necrosis factor in synovial exudates. Ann. Rheum. Dis. 47, 768–772 (1988). · doi:10.1136/ard.47.9.768
  33. Ruspi, G. et al. TNFR2 increases the sensitivity of ligand-induced activation of the p38 MAPK and NF-kappaB pathways and signals TRAF2 protein degradation in macrophages. Cell Signal. 26, 683–690 (2014). · DOI
  34. Siegmund, D., Ehrenschwender, M. & Wajant, H. TNFR2 unlocks a RIPK1 kinase activity-dependent mode of proinflammatory TNFR1 signaling. Cell Death Dis. 9, 921 (2018). · DOI
  35. Scott, D. L., Wolfe, F. & Huizinga, T. W. Rheumatoid arthritis. Lancet 376, 1094–1108 (2010). · DOI · Paper page
  36. Hyrich, K. L. et al. Outcomes after switching from one anti-tumor necrosis factor alpha agent to a second anti-tumor necrosis factor alpha agent in patients with rheumatoid arthritis: results from a large UK national cohort study. Arthritis Rheum. 56, 13–20 (2007). · DOI · Paper page
  37. Hetland, M. L. et al. Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry. Arthritis Rheum. 62, 22–32 (2010). · DOI
  38. Gottenberg, J. E. et al. Non-TNF-targeted biologic vs a second anti-TNF drug to treat rheumatoid arthritis in patients with insufficient response to a first anti-TNF drug: a randomized clinical trial. JAMA 316, 1172–1180 (2016). · DOI · Paper page
  39. Rossi, D., Modena, V., Sciascia, S. & Roccatello, D. Rheumatoid arthritis: biological therapy other than anti-TNF. Int. Immunopharmacol. 27, 185–188 (2015). · DOI

Cited by

See all 13

Metadata

Authors
Liu, S., Fu, Y., Mei, K., Jiang, Y., Sun, X., Wang, Y., Ren, F., Jiang, C., Meng, L., Lu, S., Qin, Z., Dong, C., Wang, X., Chang, Z., & Yang, S.
Venue
Cellular & Molecular Immunology
Published
2020-09-22
Volume
18
Issue
8
Pages
1883-1895
ISSN
  • 1672-7681
  • 2042-0226
Cited by
13
References
1
Language
en
Licence
Funders
National Natural Science Foundation of China (81830092, 81572729, 81872244)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A shedding soluble form of interleukin-17 receptor D exacerbates collagen-induced arthritis through facilitating TNF-α-dependent receptor clustering. https://app.cochat.ai/papers/10.1038/s41423-020-00548-w
The paper
Liu, S., Fu, Y., Mei, K., Jiang, Y., Sun, X., Wang, Y., Ren, F., Jiang, C., Meng, L., Lu, S., Qin, Z., Dong, C., Wang, X., Chang, Z., & Yang, S. (2021). A shedding soluble form of interleukin-17 receptor D exacerbates collagen-induced arthritis through facilitating TNF-α-dependent receptor clustering. Cellular & Molecular Immunology. https://doi.org/10.1038/s41423-020-00548-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.